Biological nurse specialist: Goodwill to good practice

British Journal of Nursing

Volumn 19, Issue 8, 2010, Pages 477-480

  Palmer, Deborah ^a   El Miedany, Yasser ^a  

^a DARENT VALLEY HOSPITAL   (United Kingdom)

Author keywords

Biological therapy; IMID centres; Immune mediated inflammatory disorders; Rheumatoid arthritis; Rheumatology; Specialist nurses

Indexed keywords

ANTIINFLAMMATORY AGENT;

ADVANCED PRACTICE NURSING; ARTICLE; BIOLOGICAL THERAPY; CLINICAL PATHWAY; CROHN DISEASE; DRUG MONITORING; EDUCATION; HUMAN; INFUSION; MASS SCREENING; METHODOLOGY; NURSE; NURSE ATTITUDE; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PRESCRIPTION; PSORIASIS; RHEUMATIC DISEASE;

ADVANCED PRACTICE NURSING; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL THERAPY; CRITICAL PATHWAYS; CROHN DISEASE; DRUG MONITORING; DRUG PRESCRIPTIONS; HOME INFUSION THERAPY; HUMANS; MASS SCREENING; NURSE CLINICIANS; NURSE'S ROLE; PATIENT EDUCATION AS TOPIC; PSORIASIS; RHEUMATIC DISEASES;

EID: 77954897989     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.8.47632     Document Type: Article

References (21)

1. Aletaha D, Funovits J, Keystone EC, Smolen JS (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56(10): 3226-35
2. Cheung W Garratt A, Russell I, Williams J (2000) The UK IBDQ-a British version of the inflammatory bowel disease questionnaire: development and validation. J Clin Epidemiol 53(3): 297-306
3. st Century. DH, London. tinyurl.com/exp-patient
4. Department of Health (2006) The Musculoskeletal Services Framework-a Joint Responsibility: Doing Things Differently. DH, London. tinyurl.com/musculo- frame
5. Department of Health (2006) Modernising Nursing Careers-Setting the Direction. DH, London. tinyurl.com/mod-nurse-careers
6. Fredriksson T, Pettersson U (1978) Severe psoriasis-oral therapy with a new retinoid. Dermatologien 157(4): 238-44
7. Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) Maintenance infliximab for Crohn's disease: theACCENT I randomised trial. Lancet 359(9317): 1541-9
8. Hanauer SB, Sandborn WJ, Rutgeerts P et al (2006) Human anti-tumour necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology; 130(2): 323-33
9. Hench PS, Kendall EC, Slocumb CH (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proe 24(8): 181-97
10. Klareskog L, van der Heijde D, de Jager JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363(9410): 675-81
11. Kuek A, Hazleman B, Ostör A (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007; 83(978): 251-60
12. National Institute for Health and Clinical Excellence (2002) Guidance on the Use of Etanereept and Infliximab for the Treatment of Rheumatoid Arthritis.Available at: www. nice.org.uk/nicemedia/pdf/ra-pdf.pdf (accessed 15 April 2010)
13. National Institute for Health, and Clinical Excellence (2003). NICE implementation uptake report: anakinra for rheumatoid arthritis. . Available, at: http://www.nice.org.uk/media/543/AF/UptakeReportTA72Anakinra.pdf (accessed 15 April 2010)
14. National Institute for Health and Clinical Excellence (2007) Rituximab for the Treatment of Rheumatoid Arthritis. www. nice.org.uk/nicemedia/pdf/ TA126guidance.pdf
15. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability and increased mortality in seventy five RA patients studied over nine years. Arthritis Rheum 27(8): 864-72.
16. Popa C, Leandro MJ, Cambridge G, Edwards JC (2007) Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology (Oxford) 46(4): 626-30
17. Royal College of Nursing (2003) Assessing, Managing and Monitoring Biologie Therapies for Inflammatory Arthritis. Guidance for RheumatologyPraetitioners. Royal College of Nursing, London. tinyurl.com/rcn-biologic
18. Schreiber S, Rutgeerts P, Fedorak RN et al (2005) A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology 129(3): 807-18.
19. Erratum in: Gastroenterology (2005) 129(5): 1808. Dosage error in article text
20. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20(3): 579-81
21. Young A, Dixey J, Kulinskaya E et al (2002) Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the early RA study (ERAS). Ann Rheum Dis 61(4): 335-40